Seizures in anti‐Hu‐associated extra‐limbic encephalitis: Characterization of a unique disease manifestation

Abstract

Anti-Hu-associated neurologic autoimmunity most often occurs in the context of small-cell lung cancer and typically presents with peripheral neuropathy, cerebellar ataxia and/or limbic encephalitis. Extra-limbic encephalitis causing seizures is a rare disease manifestation, with only sparse reports in the literature. We herein present a patient with seizures in anti-Hu-associated extra-limbic encephalitis, and review the literature for other cases to more fully characterise this entity. Among 27 patients we identified, the median age was 46 years (range: 2-69 years) and 18/27 (67%) were ...

Seguir leyendo →
0

Drug resistance in idiopathic generalized epilepsies: Evidence and concepts

Abstract

Although approximately 10%–15% of patients with idiopathic generalized epilepsy (IGE)/genetic generalized epilepsy remain drug-resistant, there is no consensus or established concept regarding the underlying mechanisms and prevalence. This review summarizes the recent data and the current hypotheses on mechanisms that may contribute to drug-resistant IGE. A literature search was conducted in PubMed and Embase for studies on mechanisms of drug resistance published since 1980. The literature shows neither consensus on the definition nor a widely accepted model to explain drug ...

Seguir leyendo →
0

Progressive slowing of clonic phase predicts postictal generalized EEG suppression

Abstract

Objective

Postictal generalized EEG suppression (PGES) is a surrogate marker of sudden unexpected death in epilepsy (SUDEP). It is still unclear which ictal phenomena lead to prolonged PGES and increased risk of SUDEP. Semiology features of generalized convulsive seizures (GCS type 1) have been reported as a predictor of prolonged PGES. Progressive slowing of clonic phase (PSCP) has been observed in GCSs, with gradually increasing inhibitory periods interrupting the tonic contractions. We hypothesized that PSCP is associated with prolonged PGES.

Methods

We analyzed ...

Seguir leyendo →
0

Fenfluramine provides clinically meaningful reduction in frequency of drop seizures in patients with Lennox‐Gastaut syndrome: interim analysis of an open‐label extension study

Abstract

Objective

To evaluate the long-term safety and effectiveness of fenfluramine in patients with Lennox-Gastaut syndrome (LGS).

Methods

Eligible patients with LGS who completed a 14-week phase 3 randomized clinical trial enrolled in an open-label extension (OLE; NCT03355209). All patients were initially started on 0.2 mg/kg/day fenfluramine and, after 1 month, were titrated to effectiveness and tolerability, which were assessed at 3-month intervals. The protocol-specified treatment duration was 12 months, but COVID-19-related delays resulted in 142 patients completing their final visit after 12 months.

Results

As ...

Seguir leyendo →
0

Deficit in observational learning in experimental epilepsy

Abstract

Individuals use the observation of a conspecific to learn new behaviors and skills in many species. Whether observational learning is affected in epilepsy is not known. Using the pilocarpine rat model of epilepsy, we assessed learning by observation in a spatial task.

The task involves a naïve animal observing a demonstrator animal seeking a reward at a specific spatial location. After five observational sessions, the observer is allowed to explore the rewarded space and look for the reward.

Although control observer rats ...

Seguir leyendo →
0

Paroxysmal fast activity is a biomarker of treatment response in deep brain stimulation for Lennox–Gastaut syndrome

Abstract

Objective

Epilepsy treatment trials typically rely on seizure diaries to determine seizure frequency, but these are time-consuming and difficult to maintain accurately. Fast, reliable, and objective biomarkers of treatment response are needed, particularly in Lennox–Gastaut syndrome (LGS), where high seizure frequency and comorbid cognitive and behavioral issues are additional obstacles to accurate diary-keeping. Here, we measured generalized paroxysmal fast activity (GPFA), a key interictal electrographic feature of LGS, and correlated GPFA burden with seizure diaries during a thalamic deep brain stimulation ...

Seguir leyendo →
0

Ablation of Apparent Diffusion Coefficient Hyperintensity Clusters in Mesial Temporal Lobe Epilepsy Improves Seizure Outcomes after Laser Interstitial Thermal Therapy

Abstract

Objective

Laser Interstitial Thermal Therapy (LiTT) is a minimally invasive surgical procedure for intractable mesial temporal epilepsy (mTLE). LiTT is safe and effective, but seizure outcomes are highly variable due to patient variability, suboptimal targeting, and incomplete ablation of the epileptogenic zone. Apparent Diffusion Coefficient (ADC) is an MRI sequence that can identify potential epileptogenic foci in the mesial temporal lobe to improve ablation and seizure outcomes. The objective of this study was to investigate whether ablation of tissue clusters with ...

Seguir leyendo →
0

Altered Cerebellar‐Motor Loop in Benign Adult Familial Myoclonic Epilepsy Type 1: The Structural Basis of Cortical Tremor

Abstract

Objective

Cortical tremor/myoclonus is the hallmark feature of benign adult familial myoclonic epilepsy (BAFME), which mechanism remains elusive. A hypothesis is that a defective control in the pre-existing cerebellar-motor loop drives cortical tremor. Meanwhile, the basal ganglia system might also participate in BAFME. This study aimed to discover the structural basis of cortical tremor/myoclonus in BAFME.

Methods

Nineteen patients with BAFME type 1 (BAFME1) and thirty matched healthy controls underwent T1-weighted and DTI scans. FreeSurfer and SUIT toolboxes were utilized to assess the ...

Seguir leyendo →
0

Epilepsy and its neurobehavioral comorbidities: insights gained from animal models

Abstract

It is well established that epilepsy is associated with numerous neurobehavioral comorbidities, with a bidirectional relationship: People with epilepsy have an increased incidence of depression, anxiety, learning and memory difficulties, and numerous other psychosocial challenges, and the occurrence of epilepsy is higher in individuals with those comorbidities. Although the cause-and-effect relationship is uncertain, a fuller understanding of the mechanisms of comorbidities within the epilepsies could lead to improved therapeutics. Here, we review recent data on epilepsy and its neurobehavioral comorbidities, ...

Seguir leyendo →
0

A systems medicine strategy to predict the efficacy of drugs for monogenic epilepsies

Abstract

Objective

Monogenic epilepsies are rare but often severe. Because of their rarity, they are neglected by traditional drug developers. Hence, many lack effective treatments. Treatments for a disease can be discovered more quickly and economically by computationally predicting drugs that can be repurposed for it. We aimed to create a computational method to predict the efficacy of drugs for monogenic epilepsies, and to use the method to predict drugs for Dravet syndrome, as (1) it is the archetypal monogenic catastrophic epilepsy, ...

Seguir leyendo →
0
Página 65 de 243 «...4050606364656667...»